ID OS 187 AC CVCL_1R50 SY OS-187; OS187 DR BioSample; SAMN03151646 DR cancercelllines; CVCL_1R50 DR Wikidata; Q54936532 RX PubMed=15026342; RX PubMed=18483362; RX PubMed=24046071; WW Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx CC Problematic cell line: Contaminated. Shown to be a HCT 15 derivative (PubMed=24046071). Originally thought to originate from an osteosarcoma. CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00485. CC Population: Caucasian. CC Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg727Met (c.2180G>T); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Lys993Asn (c.2979G>T); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile1417Leufs*2 (c.4248delC); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2166Ter (c.6496C>T); ClinVar=VCV000438883; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; c.68-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Tyr30Ter (c.90C>A); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1200Terfs (c.3599_3600delGT) (3827delGT); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Arg145Trp (c.433C>T); ClinVar=VCV000005592; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Asp549Asn (c.1645G>A); ClinVar=VCV000375900; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.1101-2A>C; ClinVar=VCV000635383; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line). CC Derived from site: In situ; Colon; UBERON=UBERON_0001155. CC Cell type: Epithelial cell of colon; CL=CL_0011108. DI NCIt; C4349; Colon adenocarcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_0292 ! HCT 15 SX Male AG 67Y CA Cancer cell line DT Created: 08-07-15; Last updated: 10-04-25; Version: 20 // RX PubMed=15026342; DOI=10.1158/0008-5472.CAN-03-3096; RA Hughes, Dennis Patrick Meehan RA Thomas, Dafydd G. RA Giordano, Thomas J. RA Baker, Laurence H. RA McDonagh, Kevin T. RT "Cell surface expression of epidermal growth factor receptor and Her-2 RT with nuclear expression of Her-4 in primary osteosarcoma."; RL Cancer Res. 64:2047-2053(2004). // RX PubMed=18483362; DOI=10.1158/1078-0432.CCR-07-1992; PMCID=PMC2830718; RA Zhang, Ping-Yu RA Yang, Yan-Wen RA Zweidler-McKay, Patrick A. RA Hughes, Dennis Patrick Meehan RT "Critical role of Notch signaling in osteosarcoma invasion and RT metastasis."; RL Clin. Cancer Res. 14:2962-2969(2008). // RX PubMed=24046071; DOI=10.1158/1078-0432.CCR-13-1914; PMCID=PMC4375543; RA Zhang, Ping-Yu RA Yang, Yan-Wen RA Zweidler-McKay, Patrick A. RA Hughes, Dennis Patrick Meehan RT "Retraction to 'Critical role of Notch signaling in osteosarcoma invasion RT and metastasis'."; RL Clin. Cancer Res. 19:5256-5257(2013). //